ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2503

CD8+Foxp3-CD103+ Regulatory T Cells Generated Ex Vivo with TGF-β Suppress Autoimmunity Through IL-10-Dependet Mechanism

Ya Liu1, An-Ping Xu2, David A. Horwitz3 and Song G. Zheng4, 1Medicine, USC Keck School of Medicine, Los Angeles, CA, 2Kidney disease and rheumatology, 2nd Affiliated Hospital of Sun Yat-sen University, 3Medicine-Rheumatology-Immun, Keck School of Medicine of USC, Los Angeles, CA, 4Medicine, Keck School of Medicine of USC, Los Angeles, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoimmune diseases, CD T cells, cell biology and regulatory cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

TGF-β is crucial for induction of CD4+Foxp3+ Tregs and maintenance of immunologic tolerance. It is, however, unclear if TGF-β also induces the similar CD8+ Tregs.

Methods:

CD8+Foxp3- cells isolated from Foxp3-GFP knock-in mice were stimulated with anti-CD3/28 antibodies and IL-2 with (Tregs) or without TGF-β (Tcon cells). After 3-4 days, Granzyme A/B, Perforin and other Tregs related markers were examined by FACS staining. GFP+, GFP-, GFP+CD103+, GFP+CD103-, and GFP-CD103- were sorted. Suppressive activity in vitro was examined by adding various ratios of CD8+ subsets to responder T cells. Anti-TGF-β, anti-IL-10R, or the TGF-β receptor I (ALK5) inhibitor was added to some cultures. The effect of CD8+ Tregs in vivo was tested following iv injection with 5 x105  C57BL/6 CD4+CD45RBhighcells to Rag2-/- mice. CD8+ iTregs were also injected to Experimental Allergic Encephalomyelitis (EAE) model and lupus-like chronic Graft-versus-host disease (GVHD) model.

Results: While CD8+ iTregs displayed much low Foxp3 expression compared with compartment CD4+ cells, their suppression activity in vitro and in vivo was equivalent or even better. These cells did not express Granzyme A, B or Perforin A and lacked cytotoxic activity on T response cells. CD8+ iTregs generated from Granzyme B and Perforn A KO mice still suppressed autoimmunity. Transwell experiments revealed that cell-contact is required for their suppression. CD8+ iTregs infusion markedly suppressed experimental colitis, EAE and cGVHD. Both Foxp3- and Foxp3+ subsets from TGF-primed CD8+ cells had suppressive activities. Among CD8+Foxp3- cells, CD103 is crucial for their generation and function since CD8+ but not CD4+ iTreg production decreased on CD103 KO mice. CD4+CD103+Foxp3- subset suppressed colitis through IL-10 signal. 

Results: 

While CD8+ cells primed with TGF-β (CD8+ iTregs) displayed much low Foxp3 expression compared with compartment CD4+ cells, their suppression activity in vitro and in vivo was equivalent or even better than CD4+ Tregs. These cells did not express Granzyme A, Granzyme B or Perforin A and lacked cytotoxic activity on T response cells. Additionally, CD8+ iTregs generated from Granzyme B and Perforn A KO mice still suppressed autoimmunity. Transwell experiments revealed that cell-contact is required for their suppressive activity. Adoptive transfer of the CD8+ iTregs markedly suppressed experimental colitis, EAE and cGVHD. We further found both Foxp3- and Foxp3+ subsets from TGF-primed CD8+ cells had suppressive activities. Among CD8+Foxp3- cells, we identified CD103 expression is crucial for their generation and function since CD8+ but not CD4+ iTreg production decreased on CD103 KO mice. Adoptive transfer of CD4+CD103+Foxp3- subset suppressed colitis and EAE and IL-10 signal seems to be crucial for this therapeutic effect. 

Conclusion:

TGF-β can induce CD8+Foxp3- and CD8+Foxp3+ iTreg subsets that displayed suppressive activity in cell contact-dependent, non-cytotoxic manner and have protective effects on autoimmune diseases. Generation of CD8+ iTregs may have considerable therapeutic potential on patients with autoimmune diseases.


Disclosure:

Y. Liu,
None;

A. P. Xu,
None;

D. A. Horwitz,
None;

S. G. Zheng,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd8foxp3-cd103-regulatory-t-cells-generated-ex-vivo-with-tgf-%ce%b2-suppress-autoimmunity-through-il-10-dependet-mechanism/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology